B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
Clinical trial NCT01156922 · TERMINATED
Trial details
- NCT number
- NCT01156922
- Sponsor
- Haukeland University Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2016-04-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.